UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

FRI0560 The Increase in The Nationwide Incidence of Inflammatory Rheumatic Diseases in Finland during This Millennium

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.643-644

2016

Volltextzugriff (PDF)

The feasibility of existing JADAS10 cut-off values in clinical practice: a study of data from The Finnish Rheumatology Quality Register

Pediatric rheumatology online journal, 2023-04, Vol.21 (1), p.35-35, Article 35

2023

Volltextzugriff (PDF)

Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis

Rheumatology international, 2022-06, Vol.42 (6), p.1015-1025

2022

Volltextzugriff (PDF)

FRI0061 The Concomitance of Inflammatory Bowel Disease with Incident Rheumatoid Arthritis and Ankylosing Spondylitis in Finland

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.403-404

2014

Volltextzugriff (PDF)

THU0160 Excellent Outcomes Sustained Even in Long-Term When Targeted Treatment with A Combination of Traditional DMARDs Is Used in Early Rheumatoid Arthritis. The 10-Year Follow-Up Results of A Randomized Clinical Trial, The NEO-RACO Trial

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.240-241

2016

Volltextzugriff (PDF)

SAT0027 Targeted Treatment and Combination Dmard Therapy are Additively Important for Maintaining Work Ability in Early Rheumatoid Arthritis

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A588-A589

2013

Volltextzugriff (PDF)

SAT0026 Targeted Treatment and Combination Dmard Therapy are Additively Important for Reaching Remission in Early Rheumatoid Arthritis

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A588-A588

2013

Volltextzugriff (PDF)

SAT0154 A 6-Month Induction Treatment with Infliximab Added on Intensive Combination Therapy with Conventional Dmards and Low-Dose Prednisolone Saves Work Productivity Loss During the First Treatment Year in Patients with Early Rheumatoid Arthritis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.707

2015

Volltextzugriff (PDF)

THU0119 Impact of Neglecting Intra-Articular Glucocorticoid-Injections in Remission Targeted Treatment of Early Rheumatoid Arthritis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.237-237

2015

Volltextzugriff (PDF)

AB0362 Depressive Symptoms and the Risk of Work Disability in Early Rheumatoid Arthritis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1014-1014

2015

Volltextzugriff (PDF)

Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trials

Clinical and experimental rheumatology, 2016-11, Vol.34 (6), p.1065

2016

Volltextzugriff (PDF)

SAT0028 Strict Acr-Remission within 6 Months Predicts Sustained Long-Term Very Low Disease Activity in Actively Treated Rheumatoid Arthritis Patients, 5-Year Results of the Neo-Raco Trial

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A589-A589

2013

Volltextzugriff (PDF)

OP0065 Initial Infliximab is not Cost-Effective in Otherwise Actively Treated Early Rheumatoid Arthritis. the 2-Year Follow-Up Results of the Randomized Clinical Neo-Raco Trial

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.85-85

2014

Volltextzugriff (PDF)

Impact of physicians' adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial

Scandinavian journal of rheumatology, 2015-11, Vol.44 (6), p.449-455

2015

Volltextzugriff (PDF)

FRI0544 Self-experienced risk for loss of work productivity among patients with ra seen in rheumatology outpatient clinics in finland

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A559-A559

2013

Volltextzugriff (PDF)

FRI0092 Disease activity at three months is an excellent predictor of long-term treatment failure in actively treated rheumatoid arthritis patients, 5-year results of the neo-raco trial

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A400-A401

2013

Volltextzugriff (PDF)

Long-Term Work Productivity Costs Among Subjects With Early Rheumatoid Arthritis - A Nationwide Analysis Based on 7,831 Subjects' Sickness Absence Days and Income

Value in health, 2014-11, Vol.17 (7), p.A383-A383

2014

Volltextzugriff (PDF)

Psychiatric and cardiovascular comorbidities as causes of long-term work disability among individuals with recent-onset rheumatoid arthritis

Scandinavian journal of rheumatology, 2015-01, Vol.44 (2), p.87-92

2015

Volltextzugriff (PDF)

THU0178 Rates of Serious Infections and Malignancies among Rheumatoid Arthritis Patients Receiving Either Tnf-Blocker or Rituximab Therapy in Finland

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.242-242

2014

Volltextzugriff (PDF)

Trends in treatment strategies and the usage of different disease-modifying anti-rheumatic drugs in early rheumatoid arthritis in Finland. Results from a nationwide register in 2000-2007

Scandinavian journal of rheumatology, 2011-01, Vol.40 (1), p.16-21

2011

Volltextzugriff (PDF)

OP0147 Targeted treatment with combination DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of the neo-raco trial

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.103-103

2013

Volltextzugriff (PDF)

Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study

Journal of rheumatology, 2012-10, Vol.39 (10), p.2008

2012

Volltextzugriff (PDF)

Renal safety of initial combination versus single DMARD therapy in patients with early rheumatoid arthritis: an 11-year experience from the FIN-RACo Trial

Clinical and experimental rheumatology, 2010-01, Vol.28 (1), p.73

2010

Volltextzugriff (PDF)

Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes

Clinical nephrology, 1999-12, Vol.52 (6), p.363

1999

Volltextzugriff (PDF)

SAT0154 A 6-Month Induction Treatment with Infliximab Added on Intensive Combination Therapy with Conventional Dmards and Low-Dose Prednisolone Saves Work Productivity Loss During the First Treatment Year in Patients with Early Rheumatoid Arthritis: Table 1

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.707-708

2015

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Englisch
(46)
Finnisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(30)
Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Middle Aged
(22)
Female
(20)
Male
(20)
Adult
(15)
Aged
(15)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Rheumatology
(10)
Diabetes Mellitus, Type 2 - Genetics
(9)
Diabetes. Impaired Glucose Tolerance
(8)
Endocrine Pancreas. Apud Cells
(8)
Endocrinopathies
(8)
Polymorphism, Genetic
(8)
Antirheumatic Agents - Therapeutic Use
(7)
Genotype
(7)
Arthritis, Rheumatoid - Drug Therapy
(6)
Methotrexate - Therapeutic Use
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FRI0560 The Increase in The Nationwide Incidence of Inflammatory Rheumatic Diseases in Finland during This Millennium

The feasibility of existing JADAS10 cut-off values in clinical practice: a study of data from The Finnish Rheumatology Quality Register

Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis

FRI0061 The Concomitance of Inflammatory Bowel Disease with Incident Rheumatoid Arthritis and Ankylosing Spondylitis in Finland

THU0160 Excellent Outcomes Sustained Even in Long-Term When Targeted Treatment with A Combination of Traditional DMARDs Is Used in Early Rheumatoid Arthritis. The 10-Year Follow-Up Results of A Randomized Clinical Trial, The NEO-RACO Trial

SAT0027 Targeted Treatment and Combination Dmard Therapy are Additively Important for Maintaining Work Ability in Early Rheumatoid Arthritis

SAT0026 Targeted Treatment and Combination Dmard Therapy are Additively Important for Reaching Remission in Early Rheumatoid Arthritis

SAT0154 A 6-Month Induction Treatment with Infliximab Added on Intensive Combination Therapy with Conventional Dmards and Low-Dose Prednisolone Saves Work Productivity Loss During the First Treatment Year in Patients with Early Rheumatoid Arthritis

THU0119 Impact of Neglecting Intra-Articular Glucocorticoid-Injections in Remission Targeted Treatment of Early Rheumatoid Arthritis

AB0362 Depressive Symptoms and the Risk of Work Disability in Early Rheumatoid Arthritis

Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trials

SAT0028 Strict Acr-Remission within 6 Months Predicts Sustained Long-Term Very Low Disease Activity in Actively Treated Rheumatoid Arthritis Patients, 5-Year Results of the Neo-Raco Trial

OP0065 Initial Infliximab is not Cost-Effective in Otherwise Actively Treated Early Rheumatoid Arthritis. the 2-Year Follow-Up Results of the Randomized Clinical Neo-Raco Trial

Impact of physicians' adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial

FRI0544 Self-experienced risk for loss of work productivity among patients with ra seen in rheumatology outpatient clinics in finland

FRI0092 Disease activity at three months is an excellent predictor of long-term treatment failure in actively treated rheumatoid arthritis patients, 5-year results of the neo-raco trial

Long-Term Work Productivity Costs Among Subjects With Early Rheumatoid Arthritis - A Nationwide Analysis Based on 7,831 Subjects' Sickness Absence Days and Income

Psychiatric and cardiovascular comorbidities as causes of long-term work disability among individuals with recent-onset rheumatoid arthritis

THU0178 Rates of Serious Infections and Malignancies among Rheumatoid Arthritis Patients Receiving Either Tnf-Blocker or Rituximab Therapy in Finland

Trends in treatment strategies and the usage of different disease-modifying anti-rheumatic drugs in early rheumatoid arthritis in Finland. Results from a nationwide register in 2000-2007

OP0147 Targeted treatment with combination DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of the neo-raco trial

Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study

Renal safety of initial combination versus single DMARD therapy in patients with early rheumatoid arthritis: an 11-year experience from the FIN-RACo Trial

Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes

SAT0154 A 6-Month Induction Treatment with Infliximab Added on Intensive Combination Therapy with Conventional Dmards and Low-Dose Prednisolone Saves Work Productivity Loss During the First Treatment Year in Patients with Early Rheumatoid Arthritis: Table 1

Suchergebnisse filtern